Research ExplorerPublicationsOutcomes of Directional Branches of the T-Branch Off-the-She...

Outcomes of Directional Branches of the T-Branch Off-the-Shelf Multi-Branched Stent-Graft

Standard

Outcomes of Directional Branches of the T-Branch Off-the-Shelf Multi-Branched Stent-Graft. / Spanos, Konstantinos; Jakimowicz, Tomasz; Nana, Petroula; Behrendt, Christian-Alexander; Panuccio, Giuseppe; Kouvelos, George; Jama, Katarzyna; Eleshra, Ahmed; Rohlffs, Fiona; Kölbel, Tilo.

In: J CLIN MED, Vol. 11, No. 21, 6513, 02.11.2022.

Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

Harvard

Spanos, K, Jakimowicz, T, Nana, P, Behrendt, C-A, Panuccio, G, Kouvelos, G, Jama, K, Eleshra, A, Rohlffs, F & Kölbel, T 2022, 'Outcomes of Directional Branches of the T-Branch Off-the-Shelf Multi-Branched Stent-Graft', J CLIN MED, vol. 11, no. 21, 6513. https://doi.org/10.3390/jcm11216513

APA

Spanos, K., Jakimowicz, T., Nana, P., Behrendt, C-A., Panuccio, G., Kouvelos, G., Jama, K., Eleshra, A., Rohlffs, F., & Kölbel, T. (2022). Outcomes of Directional Branches of the T-Branch Off-the-Shelf Multi-Branched Stent-Graft. J CLIN MED, 11(21), [6513]. https://doi.org/10.3390/jcm11216513

Vancouver

Spanos K, Jakimowicz T, Nana P, Behrendt C-A, Panuccio G, Kouvelos G et al. Outcomes of Directional Branches of the T-Branch Off-the-Shelf Multi-Branched Stent-Graft. J CLIN MED. 2022 Nov 2;11(21). 6513. https://doi.org/10.3390/jcm11216513

Bibtex

@article{afa598ddb26e42b19abb788bfe1f5724,
title = "Outcomes of Directional Branches of the T-Branch Off-the-Shelf Multi-Branched Stent-Graft",
abstract = "BACKGROUND: A controversy on bridging covered stent (BCS) choice, between self-expanding (SECS) and balloon-expandable (BECS) stents, still exists in branched endovascular repair. This study aimed to determine the primary target vessel (TV) patency in patients treated with the t-Branch device and identify factors impairing the outcomes.METHODS: A retrospective study was undertaken, including patients treated with the t-Branch (Cook Medical, Bloomington, IN, USA) between 2014 and 2019 (early 2014-2016; late 2017-2019). The endpoint was the primary patency (CT: celiac trunk, SMA, superior mesenteric artery, RRA: right renal artery, LRA: left renal artery) during the follow-up. Any branch instability event was assessed. The factors affecting the patency were determined using multivariable regression models and Kaplan-Meier analyses.RESULTS: In total, 2018 TVs were analyzed; 1542 SECSs and 476 BECSs. The CT patency was 99.8% (SE 0.2%) at the 1st month, with no other event. The SMA patency was 97.8% (SE 1) at the 12th month. The RRA patency was 96.7% (SE 2) at the 24th month. The LRA patency was 99% (SE 0.4) at the 6th month. Relining was the only factor independently associated with the SMA patency (OR 8.27; 95% CI 1.4-4.9; p = 0.02). The freedom from instability was 62% (SE 4.3%) and 45% (SE 5.4%) at the 24th month and 36th month. No significant difference was identified between the BECSs and SECSs in the early or late experience.CONCLUSION: BCS for the t-Branch branches performed with a good primary patency during the short-term follow-up. The type of BCS did not influence the patency. Relining might be protective for SMA patency.",
author = "Konstantinos Spanos and Tomasz Jakimowicz and Petroula Nana and Christian-Alexander Behrendt and Giuseppe Panuccio and George Kouvelos and Katarzyna Jama and Ahmed Eleshra and Fiona Rohlffs and Tilo K{\"o}lbel",
year = "2022",
month = nov,
day = "2",
doi = "10.3390/jcm11216513",
language = "English",
volume = "11",
journal = "J CLIN MED",
issn = "2077-0383",
publisher = "MDPI AG",
number = "21",

}

RIS

TY - JOUR

T1 - Outcomes of Directional Branches of the T-Branch Off-the-Shelf Multi-Branched Stent-Graft

AU - Spanos, Konstantinos

AU - Jakimowicz, Tomasz

AU - Nana, Petroula

AU - Behrendt, Christian-Alexander

AU - Panuccio, Giuseppe

AU - Kouvelos, George

AU - Jama, Katarzyna

AU - Eleshra, Ahmed

AU - Rohlffs, Fiona

AU - Kölbel, Tilo

PY - 2022/11/2

Y1 - 2022/11/2

N2 - BACKGROUND: A controversy on bridging covered stent (BCS) choice, between self-expanding (SECS) and balloon-expandable (BECS) stents, still exists in branched endovascular repair. This study aimed to determine the primary target vessel (TV) patency in patients treated with the t-Branch device and identify factors impairing the outcomes.METHODS: A retrospective study was undertaken, including patients treated with the t-Branch (Cook Medical, Bloomington, IN, USA) between 2014 and 2019 (early 2014-2016; late 2017-2019). The endpoint was the primary patency (CT: celiac trunk, SMA, superior mesenteric artery, RRA: right renal artery, LRA: left renal artery) during the follow-up. Any branch instability event was assessed. The factors affecting the patency were determined using multivariable regression models and Kaplan-Meier analyses.RESULTS: In total, 2018 TVs were analyzed; 1542 SECSs and 476 BECSs. The CT patency was 99.8% (SE 0.2%) at the 1st month, with no other event. The SMA patency was 97.8% (SE 1) at the 12th month. The RRA patency was 96.7% (SE 2) at the 24th month. The LRA patency was 99% (SE 0.4) at the 6th month. Relining was the only factor independently associated with the SMA patency (OR 8.27; 95% CI 1.4-4.9; p = 0.02). The freedom from instability was 62% (SE 4.3%) and 45% (SE 5.4%) at the 24th month and 36th month. No significant difference was identified between the BECSs and SECSs in the early or late experience.CONCLUSION: BCS for the t-Branch branches performed with a good primary patency during the short-term follow-up. The type of BCS did not influence the patency. Relining might be protective for SMA patency.

AB - BACKGROUND: A controversy on bridging covered stent (BCS) choice, between self-expanding (SECS) and balloon-expandable (BECS) stents, still exists in branched endovascular repair. This study aimed to determine the primary target vessel (TV) patency in patients treated with the t-Branch device and identify factors impairing the outcomes.METHODS: A retrospective study was undertaken, including patients treated with the t-Branch (Cook Medical, Bloomington, IN, USA) between 2014 and 2019 (early 2014-2016; late 2017-2019). The endpoint was the primary patency (CT: celiac trunk, SMA, superior mesenteric artery, RRA: right renal artery, LRA: left renal artery) during the follow-up. Any branch instability event was assessed. The factors affecting the patency were determined using multivariable regression models and Kaplan-Meier analyses.RESULTS: In total, 2018 TVs were analyzed; 1542 SECSs and 476 BECSs. The CT patency was 99.8% (SE 0.2%) at the 1st month, with no other event. The SMA patency was 97.8% (SE 1) at the 12th month. The RRA patency was 96.7% (SE 2) at the 24th month. The LRA patency was 99% (SE 0.4) at the 6th month. Relining was the only factor independently associated with the SMA patency (OR 8.27; 95% CI 1.4-4.9; p = 0.02). The freedom from instability was 62% (SE 4.3%) and 45% (SE 5.4%) at the 24th month and 36th month. No significant difference was identified between the BECSs and SECSs in the early or late experience.CONCLUSION: BCS for the t-Branch branches performed with a good primary patency during the short-term follow-up. The type of BCS did not influence the patency. Relining might be protective for SMA patency.

U2 - 10.3390/jcm11216513

DO - 10.3390/jcm11216513

M3 - SCORING: Journal article

C2 - 36362739

VL - 11

JO - J CLIN MED

JF - J CLIN MED

SN - 2077-0383

IS - 21

M1 - 6513

ER -